Markedly reduced hospitalizations with inhaled steroid in small, open-label trial
Fonte: Is Asthma Tx a Breath of Fresh Air for Early COVID-19 Patients?
Será?
corticosteroides
Association Between Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
This meta-analysis pools data from 7 randomized trials to estimate the association between administration of corticosteroids vs usual care or placebo and all-cause mortality at 28 days in patients with severe coronavirus disease 2019 (COVID-19).
Corticoides diminuem mortalidade em casos graves de Covid-19, confirmam estudos
Dois estudos publicados nesta quarta-feira, 2 de setembro, confirmam a utilidade desses fármacos na terapia de casos graves da Covid-19, também marcados por uma reação inflamatória exagerada.
Fonte: Corticoides diminuem mortalidade em casos graves de Covid-19, confirmam estudos
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM
Original Article from The New England Journal of Medicine — Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Fonte: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM
Saindo do forno o trabalho sobre o benefício do corticoide em pacientes com COVID. Ansiosamente aguardado!!
Finally: Common Drug Improves COVID-19 Survival in Trial
‘A ground-breaking development,’ according to preliminary data from an ongoing trial
Fonte: Finally: Common Drug Improves COVID-19 Survival in Trial
”dexametazona em pacientes necessitando de suplementação de O2 ou ventilação mecânica.
Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS | NEJM
Original Article from The New England Journal of Medicine — Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS
Fonte: Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS | NEJM
Um conceito interessante, que abre uma linha de conduta promissora.
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock | NEJM
Original Article from The New England Journal of Medicine — Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
Fonte: Hydrocortisone plus Fludrocortisone for Adults with Septic Shock | NEJM
E esse é o outro.
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock | NEJM
Original Article from The New England Journal of Medicine — Adjunctive Glucocorticoid Therapy in Patients with Septic Shock
Fonte: Adjunctive Glucocorticoid Therapy in Patients with Septic Shock | NEJM
A última edição online da NEJM veio com dois artigos interessantes sobre o uso de corticosteróides em sépsis, com resultados não exatamente concordantes. Esse é um deles.
Corticosteroids in treating community-acquired pneumonia: has the time really come? – Clinical Microbiology and Infection
Oh God! Here we go again!
blog infectologia em geral 